Cargando…
Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
Glucagon like peptide 1 (GLP-1) based therapies are now widely used for the treatment of type 2 diabetes. Developing our understanding of intestinal GLP-1 release may facilitate the development of new therapeutics aimed at targeting the GLP-1 producing L-cells. This study was undertaken to character...
Autores principales: | Rogers, G J, Tolhurst, G, Ramzan, A, Habib, A M, Parker, H E, Gribble, F M, Reimann, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060588/ https://www.ncbi.nlm.nih.gov/pubmed/21224236 http://dx.doi.org/10.1113/jphysiol.2010.198069 |
Ejemplares similares
-
Glutamine Triggers and Potentiates Glucagon-Like Peptide-1 Secretion by Raising Cytosolic Ca(2+) and cAMP
por: Tolhurst, Gwen, et al.
Publicado: (2011) -
Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells
por: Friedlander, Ronn S, et al.
Publicado: (2011) -
Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells
por: Habib, A. M., et al.
Publicado: (2013) -
Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
por: Psichas, Arianna, et al.
Publicado: (2017) -
Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion
por: Parker, H. E., et al.
Publicado: (2012)